August 2021 - Page 7 of 8 - CannabisNewsWire

ThursdayAug 05, 2021 1:17 pm

Grapefruit USA Inc. (GPFT) Signs Agreement with Leading Canadian Cannabis Manufacturer to Offer Game-Changing THC/CBD Cream

GPFT forms strategic alliance with 6PAK Solutions Inc Company working to achieve goal of launching Hourglass in Canada in the third quarter of 2021 Grapefruit’s patented Hourglass delivery cream system has fundamentally changed the way humans absorb cannabinoids In the United States, Grapefruit USA (OTCQB: GPFT) provides consumers with one of the most effective cannabis topical creams on the market. Now, through its partnership with 6PAK Solutions Inc., Grapefruit can offer its patented Hourglass(TM) Time Release THC+CBD Delivery Topical Relief Cream in Canada too (https://cnw.fm/qeAd5). “We are very encouraged by 6PAK’s decision to form an alliance with Grapefruit to take…

ThursdayAug 05, 2021 4:20 am

420 with CNW — Study Finds That Genetics Cause Hemp Plants to Produce More THC, Not Environmental Stresses

The use of CBD in various applications, including the treatment of depression, anxiety and pain and easing symptoms associated with cancer, has made cultivating hemp for CBD a booming industry. However, when hemp contains THC that exceeds the legal limit, the crop can test “hot.” THC is the psychoactive ingredient found in marijuana that gets a person high. Federal and state regulations classify hemp as containing no more than 0.3% THC, meaning that growers can lose their entire crop if the plants exceed the stipulated THC level. Various articles and websites have claimed that biological or environmental stresses, like crop…

WednesdayAug 04, 2021 4:20 pm

420 with CNW — Researchers Opt for Creative Ways to Study Federally Prohibited Marijuana

Since its inception, America's cannabis industry has been in a precarious position. Although 37 states have legalized medical marijuana, the federal government still classifies marijuana as a Schedule I controlled substance. This has essentially shackled the state-legal cannabis industry and has been especially detrimental to cannabis research. While cannabis is said to be effective against a wide range of medical issues, there isn't a lot of scientific data backing up these claims. Since cannabis companies aren't allowed to test their products on people before releasing them to the market, they essentially rely on customer feedback to tweak and improve products.…

WednesdayAug 04, 2021 12:06 pm

Grapefruit USA Inc. (GPFT) Expands into Billion-Dollar Market with New CBD Pet Tincture

Pet CBD industry projected to reach $1.7 billion by 2025 GPFT’s new pet CBD product targets two common dog, cat ailments: anxiety and joint pain Pets deserve the same relief that their owners experience with Grapefruit’s CBD products, says CEO Humans aren’t the only ones who may benefit from all that cannabidiol (“CBD”) offers. A recent Brightfield Group article reported that the pet CBD industry has experienced significant growth over the last several years, with Brightfield projecting an expected market valuation of more than $1.7 billion by 2025 (https://cnw.fm/drv6i). Grapefruit USA (OTCQB: GPFT) is leveraging its expertise in the space…

WednesdayAug 04, 2021 11:46 am

American Cannabis Partners Success Lies in the Details and its Values

ACP operates in two states and has strategic plans in place to expand into two more by 2024 Partnerships have allowed the recreation of the exact soil conditions, growing supplements, water makeup, and environment of Orange Hill in Jamacia Junior Gordon, the Cultivation Manager of ACP, is an award-winning and highly sought after grower whose focus is primarily on plant health The privately-owned American Cannabis Partners ("ACP"), a large scale organic cannabis cultivation company, is headquartered in Northern California but also has a foothold in Michigan. Since its beginning in 2018, ACP has acquired 12 cannabis licenses, 20,000 sq. ft of…

WednesdayAug 04, 2021 11:12 am

RYAH Group Inc. (CSE: RYAH) Supporting U.S. Changes in Cannabis Research

New cultivators have approved for federally funded studies in the U.S., and 575 DEA-licensed researchers are standing by, ready for the change RYAH's ecosystem of products allows data to be collected from seed to consumption, providing a holistic view of the plant necessary for optimal research RYAH continues to expand its global clinical and distribution network for plant-based medicine and digital patient care The U.S. is putting an end to its 50-year long prohibition on Cannabis Research (https://cnw.fm/UOoHf). New cultivators have now been approved for federally funded studies. With over 575 DEA-licensed researchers across the U.S., the future of cannabis…

WednesdayAug 04, 2021 4:20 am

420 with CNW — Cannabis Sales Continue to Increase as COVID-19 Restrictions Are Lifted

The sales gains recorded in the marijuana industry after business lockdowns following the 2020 pandemic seem to be long term, with executives noting that the pandemic may have produced a new group of consumers who are trying out or using cannabis to relieve stress among other reasons. Industry executives forecast that as the U.S. economy slowly reopens and people are allowed to begin taking trips and visiting restaurants and stores, consumers of marijuana will shift their purchases in favor of discreet consumption forms such as vape pens and edibles. A study that was conducted recently by the National Federation of…

TuesdayAug 03, 2021 4:20 pm

420 with CNW — Cory Booker Reveals Ongoing Talks to Gain Biden’s Support for Cannabis Legalization

Senator Cory Booker has revealed that he and his Senate colleagues are in talks with the White House regarding cannabis legalization. Now that Senate Majority Leader Chuck Schumer, Senate Finance Committee Chairman Ron Wyden and Booker have released a discussion draft of a federal marijuana legalization bill, they are working to bring President Joe Biden on board. President Biden has said that while he supports modest cannabis reform, including medical marijuana and expunging low-level cannabis offenses from people records, he opposes broad reform. The trio released the 163-page federal cannabis bill last month, asking the public for input so they…

TuesdayAug 03, 2021 9:30 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Is ‘One to Watch’

InMed has a world class leadership team with a successful track record of drug development and commercialization The company recently announced closing of a $12 million private placement InMed has a solid and expanding intellectual property portfolio with multiple patents filed The company recently signed an LOI to acquire rare cannabinoids manufacturer BayMedica InMed retains all commercial rights to its IntegraSyn manufacturing system InMed has filed clinical trial applications in several countries as part of a Phase 2 clinical trial of INM-755 (cannabinol) cream in epidermolysis bullosa The consumer market for cannabinoid-based pharmaceuticals in the United States is forecast to…

TuesdayAug 03, 2021 9:00 am

Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) Names New Executive, Retains PR Firm

CHALF appoints retail veteran Ginger Mollo as chief integration officer, Fifth & Root GM Mollo will oversee the positioning, expansion of the Fifth & Root Brand within the health and wellness beauty market as well as integration into Chalice brands Chalice has engaged MP-IMC to heighten profile of Fifth & Root in Chalice Brands product portfolio Chalice Brands (CSE: CHAL) (OTCQB: CHALF), a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, has appointed retail veteran Ginger Mollo as chief integration officer for the company. In addition, Mollo will also serve as general manager of Fifth &…